Amyris announced that it has signed an agreement with Ingredion Incorporated for the exclusive licensing of Amyris’s zero-calorie, nature-based, fermented Reb M sweetener
The company has reported total income of Rs.1275.54 crores during the period ended March 31, 2021
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
RIL has posted net profit of Rs.49128 crores for the 12 months period ended March 31, 2021
Shchekinoazot aims to establish production of green and blue methanol, ammonia, and hydrogen using Topsoe’s experience and technologies
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
In a previous role at Ashland Chemical, George was responsible for overseeing the global launch of new technology to the market
IMCD expects operating EBITA growth in 2021
The FEED work starts immediately and is planned to be completed in the third quarter of 2021
DKSH will offer full-agency services, manage distribution as well as marketing and sales of Ovaltine to further strengthen the brand’s commercial presence in Indonesia
The agreement also includes tolling and service agreements between Solvay and OpenGate to ensure a seamless transition and minimal customer disruption.
The facility will recycle textile waste, including items such as worn-out jeans and production scraps, to manufacture 60,000 metric tons of Circulose dissolving pulp per year
Sales grew by 14% to a Q1 record-high of $1,109 million, driven by continued robust 15% volume growth
Q1 synergy-driven sales grew 45 percent year on year
Led by Key Partners Capital with participation from Astanor Ventures, Horizons Ventures and Cape Capital, the Series C cements Modern Meadow as a leader in biofabrication
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
The company has posted net profit of Rs.155.85 crores for the period ended March 31, 2021
During the three months ended March 31, 2021, the company spent $98 million on capital expenditures as compared to $61 million in the same period of 2020
Subscribe To Our Newsletter & Stay Updated
